Banner and Witcoff, LTD. Intellectual Property Law logo
Diversity  |  Pro Bono  |  Client Portal  |  Library  |  Subscribe  |    RSS Feeds  |    Blogs
search
Intellectual Property Law: Counseling,
Licensing, Litigation & Procurement
A A A
11.29.2012 | John P. Iwanicki presents on the Current Obviousness Standard and Its Implications for Biotech Patenting at ACI’s 14th Advanced Forum on Biotech Patents in Boston
John P. Iwanicki presents "Demystifying the Current Obviousness Standard and Its Implications for Biotech Patenting" at ACI’s 14th Advanced Forum on Biotech Patents in Boston

Mr. Iwanicki co-presents with Eli Lilly & Company’s Assistant General Patent Counsel, Alexander Wilson on Thursday, November 29 at 4:30 p.m. at the Hyatt Regency Boston, in Boston, MA.

Elements of the presentation will include:

  • Exploring the reaffirmation of KSR though In re Kao
    • Understanding the impact of KSR and its progeny on primary compound and compositions claims
  • Assessing the implications of Otsuka Pharm. v. Sandoz
    • Describing how Otsuka clarifies the obvious-type double patenting analysis
    • Determining the interplay between obvious-type double patenting analysis and traditional obviousness analysis elucidated in Otsuka
    • Characterizing the role of “lead compound” designation in obviousness findings
  • Utilizing obvious-type double patenting claims as a litigation tool
  • What is “structural” obviousness?
  • Grasping the growing importance of unexpected results
    • Recognizing the tension created when emphasizing unexpected results runs up against written description requirements
  • Investigating the CAFC’s trend towards granting credence towards “secondary considerations” in obviousness analysis
    • Considering the PTO’s recent embracing of secondary considerations when examining patent applications
    • Why does the CAFC weigh secondary considerations equally with unexpected results in obviousness analysis?


For more information including registration information, please visit www.americanconference.com/biotechpatents.

See attached file for more information:
ACI 2012 Biotech Patents.pdf
 
Contact Us  |  Locations  |  Disclaimer  |  Sitemap  |  Banner & Witcoff, Ltd. ©2014
design & development: Fathom Creative, Inc. (fathomcreative.com), Anthony D. Paul (anthonydpaul)